Catumaxomab

WikiDoc Resources for Catumaxomab
Articles
Most recent articles on Catumaxomab Most cited articles on Catumaxomab Review articles on Catumaxomab Articles on Catumaxomab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Catumaxomab Images of Catumaxomab Photos of Catumaxomab Podcasts & MP3s on Catumaxomab Videos on Catumaxomab
Evidence Based Medicine
Cochrane Collaboration on Catumaxomab Bandolier on Catumaxomab TRIP on Catumaxomab
Clinical Trials
Ongoing Trials on Catumaxomab at Clinical Trials.gov Trial results on Catumaxomab Clinical Trials on Catumaxomab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Catumaxomab NICE Guidance on Catumaxomab NHS PRODIGY Guidance FDA on Catumaxomab CDC on Catumaxomab
Books
Books on Catumaxomab
News
Catumaxomab in the news Be alerted to news on Catumaxomab News trends on Catumaxomab
Commentary
Blogs on Catumaxomab
Definitions
Definitions of Catumaxomab
Patient Resources / Community
Patient resources on Catumaxomab Discussion groups on Catumaxomab Patient Handouts on Catumaxomab Directions to Hospitals Treating Catumaxomab Risk calculators and risk factors for Catumaxomab
Healthcare Provider Resources
Symptoms of Catumaxomab Causes & Risk Factors for Catumaxomab Diagnostic studies for Catumaxomab Treatment of Catumaxomab
Continuing Medical Education (CME)
CME Programs on Catumaxomab
International
Catumaxomab en Espanol Catumaxomab en Francais
Business
Catumaxomab in the Marketplace Patents on Catumaxomab
Experimental / Informatics
List of terms related to Catumaxomab

Overview

Catumaxomab (removab®) is a rat-murine hybrid monoclonal antibody and which it's used to treat some cancers such as platinum-refractory ovarian cancer, malignant ascites, and gastric cancer. It binds to antigen CD3 and is also trifunctional. It is in clinical trials in the United States currently and is used in Europe.

It basically works by linking your T-lymphocytes with the cancer cells.

Template:Rat-murinehybridmonoclonals